[ON THE THERAPY OF CORONARY INSUFFICIENCY].
D000925:Anticoagulants; D003324:Coronary Artery Disease; D003327:Coronary Disease; D004071:Digitalis Glycosides; D004176:Dipyridamole; D004358:Drug Therapy; D005029:Ethylenediamines; D006493:Heparin; D006801:Humans; D009525:Niacin; D009539:Nicotinic Acids; D011299:Prenylamine; D012046:Rehabilitation; D013328:Strophanthins; D013806:Theophylline; D013812:Therapeutics; D014665:Vasodilator Agents
D000925:Anticoagulants; D004071:Digitalis Glycosides; D005029:Ethylenediamines; D009539:Nicotinic Acids; D013328:Strophanthins; D014665:Vasodilator Agents; D009525:Niacin; D004176:Dipyridamole; D006493:Heparin; D013806:Theophylline; D011299:Prenylamine
ANTICOAGULANTS; CORONARY DISEASE; DIGITALIS GLYCOSIDES; DIPYRIDAMOLE; DRUG THERAPY; ETHYLENEDIAMINES; HEPARIN; NICOTINIC ACID; PRENYLAMINE; REHABILITATION; STROPHANTHIN; THEOPHYLLINE; THERAPEUTICS; VASODILATOR AGENTS
ZUR THERAPIE DER KORONAR-INSUFFIZIENZ.